Drug Type Small molecule drug, Radiopharmaceuticals and diagnostic agent |
Synonyms |
Target- |
Mechanism Ionising radiation emitters |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization TAE Life Sciences LLCStartup |
Active Organization TAE Life Sciences LLCStartup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Breast Cancer | Preclinical | US | TAE Life Sciences LLCStartup | 15 Jun 2023 |
Glioblastoma | Preclinical | US | TAE Life Sciences LLCStartup | 15 Jun 2023 |
Head and Neck Neoplasms | Preclinical | US | TAE Life Sciences LLCStartup | 15 Jun 2023 |
Melanoma | Preclinical | US | TAE Life Sciences LLCStartup | 15 Jun 2023 |